Updates &
Announcements

View all press

June 16, 2021

Life sciences is poised to be Boston’s dominant industry. Has the area become the Silicon Valley of biotech? – The Boston Globe

Life sciences is poised to be Boston’s dominant industry. Has the area become the Silicon Valley of biotech? – The Boston Globe

June 4, 2021

Biopharma and Venture Capital: A Deep Dive – Evaluate Vantage

Biopharma and Venture Capital: A Deep Dive – Evaluate Vantage

May 4, 2021

Omega Funds’ Otello Stampacchia Participates in BIO Deutschland’s German Corona Showcase 2021

Omega Funds’ Otello Stampacchia Participates in BIO Deutschland’s German Corona Showcase 2021

April 28, 2021

Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors

Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors

April 26, 2021

Omega’s Michelle Doig joins RBC Capital Markets’ Pathfinders in Biopharma podcast

Omega’s Michelle Doig joins RBC Capital Markets’ Pathfinders in Biopharma podcast

February 12, 2021

2021: The Rise of the Variants – TimmermanReport.com

2021: The Rise of the Variants – TimmermanReport.com

January 14, 2021

Biotech Startup Acquisitions Jumped in 2020, Leaving VCs Optimistic for New Year – Wall Street Journal

Biotech Startup Acquisitions Jumped in 2020, Leaving VCs Optimistic for New Year – Wall Street Journal

January 7, 2021

Scorpion Therapeutics Announces Oversubscribed $162 Million Series B Financing

Scorpion Therapeutics Announces Oversubscribed $162 Million Series B Financing

January 7, 2021

LEXEO Therapeutics Launches with $85 Million Series A Financing to Develop Gene Therapies

LEXEO Therapeutics Launches with $85 Million Series A Financing to Develop Gene Therapies

January 7, 2021

Endeavor BioMedicines Launches with $62 Million Series A Financing and Mission to Reverse the Course of Devastating Pulmonary Disease

Endeavor BioMedicines Launches with $62 Million Series A Financing and Mission to Reverse the Course of Devastating Pulmonary Disease

January 6, 2021

Omega Alpha SPAC Announces Pricing of Its Initial Public Offering

Omega Alpha SPAC Announces Pricing of Its Initial Public Offering

Our Team
"Luck favors the prepared mind"
Louis Pasteur

Management

Deirdre Cunnane

LinkedIn

Claudio Nessi

LinkedIn

Anne-Mari Paster

LinkedIn

Alexia Pearsall

LinkedIn

Otello Stampacchia

LinkedIn

Investment Professionals

Dina Chaya

LinkedIn

Bernard Davitian

LinkedIn

Michelle Doig

LinkedIn

Francesco Draetta

LinkedIn

Thomas Goebel

LinkedIn

Paulina Hill

LinkedIn

Noelle Hutchins

LinkedIn

Katie Kerfoot

LinkedIn

Annie Mitsak

LinkedIn

Vincent Ossipow

LinkedIn

Sylvia Tobe

LinkedIn

Operations

Philipp Bliedung

LinkedIn

Gilchrist DiPrete

LinkedIn

Jun Lin

LinkedIn

Mark Russell

LinkedIn

Administration

Pennylynn Canto

LinkedIn

Estelle Decosterd

LinkedIn

Sanja Mutabdzija

LinkedIn

Caroline Napoli

LinkedIn

Ellissa Stanley

LinkedIn

Heather Weekley

LinkedIn

Advisors

Erik Amble